TLR4 and hepatocellular carcinoma: Recently Dapito et al. demonstrated that Tlr4mut mice (harbouring non-functional TLR4) that received diethylnitrosamine (DEN) and CCl4 show 80-90 % reduction in HCC tumour size and number, compared with mice expressing wild-type TLR4 [110].